巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    NovaBay Pharmaceuticals

    NBY
    0.190
    0.000
    0.89%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・NovaBay Pharmaceuticals - 延遲價格・最後更新於 27/05 3:56
    最高位
    0.208
    最低位
    0.180
    開市價
    --
    前收市價
    0.192
    成交量(千)
    4.41
    成交額(百萬)
    0.01
    買入
    0.190
    賣出
    0.194
    每手股數
    --
    市值(百萬)
    10.00
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    0.877 - 0.171
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    NovaBay Pharmaceuticals
    證券代碼
    NBY.US
    所屬板塊
    Biotechnology
    公司業務
    NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eye care market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). The company develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets.
    發行量
    41782584
    公司總部
    2000 Powell Street, Suite 1150
    公司網址
    https://www.novabay.com
    公司電郵
    jhall@novabay.com
    公司電話
    +1 510 899-8800
    暫無內容

    關於

    NovaBay Pharmaceuticals(NBY.US)所屬的行業板塊為Biotechnology。
    NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eye care market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). The company develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets.
    詳細公司背景可參考: https://www.novabay.com